Government bans 328 Fixed Dose Combinations

Image
IANS New Delhi
Last Updated : Sep 12 2018 | 2:10 PM IST

The Ministry of Health and Family Welfare on Wednesday announced prohibiting the manufacture for sale or distribution for human use of 328 Fixed Dose Combinations (FDCs) drugs with immediate effect.

It has also restricted the manufacture, sale or distribution of six FDCs subject to certain conditions, the Ministry said in a statement. FDCs are two or more drugs combined in a fixed ratio into a single dosage form.

The Centre, in March 2016, had prohibited the manufacture for sale and distribution of 349 FDCs but this was contested by the affected manufacturers in High Courts and the Supreme Court.

Complying with the December 2017 Supreme Court judgment, the Drugs Technical Advisory Board (DTAB) examined the matter and, in its report to the Centre, recommended prohibition of the FDCs saying there was no therapeutic justification for the ingredients contained in them and that these FDCs may involve risk to human beings.

Earlier, an expert committee appointed by the Centre too had made similar observations.

Considering the recommendations of DTAB and the expert committee, the Ministry of Health and Family Welfare, through a gazette notification, prohibited the FDCs.

--IANS

and/mag/mr

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 12 2018 | 2:02 PM IST

Next Story